Definitive Contract SP470123C0087

Award Date 9/28/23
Potential Completion Date 9/29/26
Potential Value $2.1M
Funding Federal Agency
Headquarters
Contracting Federal Agency
Troop Support
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Philadelphia, PA 19111, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,372,650.57 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of a variety of pharmaceutical products and medical supplies, including medications across therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,018.56, is for the provision of a range of pharmaceutical products and medical supplies, including medications across various therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The contract is not...
This is a $616,203.68 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the supply of a range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications across therapeutic areas such as diabetes, neurology, pain management, and antibiotics. This delivery order is part of a larger...
This is a $2,131,773.92 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and specialty pharmaceuticals. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery...
This is a $1,048,105.97 firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to supply a range of pharmaceutical products and medical supplies. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA to provide global pharmaceutical support, including medications across multiple therapeutic areas such as diabetes,...
This federal contract award, valued at $893,428.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, supporting the Medical Supply Chain program within the Defense agency. The contract covers a wide range of pharmaceutical and medical products, including medications across various therapeutic areas such as diabetes, neurology, pain...
This is a $531,905.39 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics, to support military and government healthcare programs. The contract is not set aside and was awarded under...
This is a $36,556.95 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of various pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes treatments, neurological medications, pain management pharmaceuticals, hormone treatments, and antibiotics. The contract is...
This is a $1,738,383.14 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price arrangement with a period of performance through May 8, 2024. It is not set aside for any specific business type, indicating open competition. The contract provides for the delivery of a comprehensive range of pharmaceutical products, medical supplies, and healthcare...
This federal contract award, valued at $827,657.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the ultimate completion date is May 22, 2024. The contract provides for the delivery of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications across...

This is a $2,052,779.38 firm-fixed-price definitive contract awarded by the Department of Defense's Headquarters to Global Healthcare Exchange, LLC, a foreign-owned for-profit organization. The contract is for GHX Data Subscription services to support the Defense Logistics Agency's (DLA) acquisition of medical supplies for the military. This is the third federal contract awarded to Global Healthcare Exchange by DLA since 2020, totaling over $6.5 million for GHX's data cleansing and subscription offerings to enhance DLA's supply chain management. The contract has a period of performance from September 2023 through September 2026 and does not have a set-aside designation.

Generated 7/12/24, 10:24 AM